Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis (original) (raw)

QJM: An International Journal of Medicine, 2010

View PDFchevron_right

Morbidity rate of drug-susceptible tuberculosis and its medico-economic impact

Madiha Mushtaque

African Journal of Pharmacy and Pharmacology, 2020

View PDFchevron_right

Aportes al diagnóstico de resistencia a pirazinamida en Mycobacterium tuberculosis

Howard Takiff

Biotecnologia Aplicada, 2011

View PDFchevron_right

Fatal case of extensively drug-resistant Mycobacterium tuberculosis Beijing genotype infection in an injecting drug user, Athens, Greece, 2012

Ioanna Marinou

Eurosurveillance, 2013

View PDFchevron_right

Tuberculosis and HIV: Renewed Challenge

Marcus Conde

Memórias do Instituto Oswaldo Cruz, 1998

View PDFchevron_right

Mycobacterium tuberculosis: escape room world champion

Ger Rijkers

Pneumonia, 2019

View PDFchevron_right

Tuberculosis Immune Reconstitution Inflammatory Syndrome: Drug Resistance and the Critical Need for Better Diagnostics

Ian Sanne

Clinical Infectious Diseases, 2009

View PDFchevron_right

Treatment of Latent Tuberculosis Infection in Patients Aged ≥35 Years

Andrea Cruz

Clinical Infectious Diseases, 2000

View PDFchevron_right

Mycobacterium tuberculosis Drug Resistance, Ghana

Muhammad Haroon

Emerging Infectious Diseases, 2006

View PDFchevron_right

The Risk of Latent Tuberculosis Reactivation in COVID-19 Therapy

Ghina Mutiara Abas

Jurnal Biomedika dan Kesehatan, 2023

View PDFchevron_right

A Recent Review on Tuberculosis and Its Treatment

Kumud Upadhyaya

International journal of research in pharmacy and chemistry, 2019

View PDFchevron_right

Incidence of Tuberculosis as a Opportunistic Infection in Patients with HIV Getting Combined Anti Retroviral Therapy

Aarati Acharya

Medical Journal of Pokhara Academy of Health Sciences, 2019

View PDFchevron_right

Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007

Ibrahim Abubakar

JAMA, 2008

View PDFchevron_right

Outcomes of Multidrug-Resistant Tuberculosis among Binational Cases in El Paso, Texas

priyanka boppe

American Journal of Tropical Medicine and Hygiene, 2010

View PDFchevron_right

An unexpected case of disseminated tuberculosis from tumour necrosis factor inhibition

Robert Macginley

2020

View PDFchevron_right

Tuberculosis caused by RD^Rio Mycobacterium tuberculosis is not associated with differential clinical features

Neio Boéchat

The International Journal of Tuberculosis and Lung Disease, 2012

View PDFchevron_right

Drug Resistant Pattern of M. tuberculosis -An Emerging Threat for Public Health

Taha Nazir

View PDFchevron_right

Tuberculosis and noncommunicable diseases: neglected links and missed opportunities

Mario Raviglione

European Respiratory Journal, 2010

View PDFchevron_right

Research Priorities for HIV/M. tuberculosis Co-Infection

Pradeep Seth

The Open Infectious Diseases Journal, 2011

View PDFchevron_right

Movement of Tuberculosis Patients and the Failure to Complete Antituberculosis Treatment

Janet Mohle-Boetani

American Journal of Respiratory and Critical Care Medicine, 1998

View PDFchevron_right

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

Markus Maeurer

The Lancet Infectious Diseases, 2018

View PDFchevron_right

Persistence of Mycobacterium tuberculosis in response to infection burden and host-induced stressors

Haiko Schurz

Frontiers in Cellular and Infection Microbiology, 2022

View PDFchevron_right

Clinical Outcomes Among Persons With Pulmonary Tuberculosis Caused by Mycobacterium tuberculosis Isolates With Phenotypic Heterogeneity in Results of Drug-Susceptibility Tests

Ronald Ncube

Journal of Infectious Diseases, 2014

View PDFchevron_right

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis (original) (raw)

Related papers